Ensuring Patient Access to Critical Breakthrough Products Act
Health119-hr5343 — Ensuring Patient Access to Critical Breakthrough Products Act. Sponsored by Rep. Moore, Blake D. [R-UT-1]. Introduced 2025-09-15. House bill. 119th Congress. Latest action: Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3.
Amendment Analysis None
Text Versions
1
This bill was amended during the legislative process.
- Sponsor
- Rep. Moore, Blake D. [R-UT-1] (R), UT
- Introduced
- 2025-09-15
- Committees
- Ways and Means Committee; Energy and Commerce Committee
- Subjects
- Congressional oversight; Drug safety, medical device, and laboratory regulation; Health care costs and insurance; Health care coverage and access; Health programs administration and funding; Health technology, devices, supplies; Medicare
- Latest Action
- Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3.
No roll-call vote data available for this bill.
Similar Bills
- 119-s1717 — Ensuring Patient Access to Critical Breakthrough Products Act of 2025 62% match
- 118-s5349 — Ensuring Patient Access to Critical Breakthrough Products Act of 2024 61% match 118th Congress
- 119-hr5587 — HEATS Act 61% match
- 118-hr6462 — READINESS Act 61% match 118th Congress
- 118-hr5040 — H.R. 5040, CURE Act 59% match 118th Congress
Investigate this bill →
Beneficiary scoring, topic classification, and fiscal analysis